Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 09/30/2021

DCTD’s Translational Research Program (TRP) Announces Fiscal Year 2021 SPORE Grantees


The TRP recently announced its successfully competed FY2021 Specialized Programs of Research Excellence (SPORE) grantees.

The SPORE program uses the P50 and U54 grant funding mechanisms to promote collaborative, interdisciplinary, translational cancer multi-project research. SPOREs are primarily focused on organ site disease, but also on themes that cut across organ sites.

There are now 57 funded SPOREs located at academic centers in 21 states. See information about all SPOREs by organ site and by state.


FY 2021 SPORE Grantees

Principal Investigator Institution Cancer Type
Jean Pierre Issa (contact), Stephen Baylin, and Peter Jones Coriell Institute for Medical Research Epigenetics
Antonio Jimeno (contact) and Xiao-Jing Wang University of Colorado Head & Neck
*Wade Clapp (contact) and Kevin Shannon Indiana University-Purdue University at Indianapolis and UCSF Hyperactive Ras
Omar Abdel-Wahab (contact) and Martin Tallman Memorial Sloan Kettering Cancer Center Leukemia
*Leif Bergsagel Mayo Clinic, Arizona Myeloma
*Scott Kaufmann Mayo Clinic, Rochester Ovarian
*Kirsten Moysich (contact) and Kunle Odunsi Roswell Park Cancer Institute and U. Chicago Ovarian
**Sarki Abdulkadir (contact) and Maha Hussain Northwestern University Prostate
Meenhard Herlyn (contact) and Ravi Amaravadi Wistar Institute and University of Pennsylvania Skin
Hassane Zarour (contact) and John Kirkwood University of Pittsburgh Skin

*Grant Renewal       **Grant Renewal/New PI

Goals of the SPORE Program

  • Translating novel scientific discoveries from the laboratory and/or population studies to the clinic for testing in humans with cancer or at risk for cancer
  • Determining the biological basis for clinical observations
  • Using specimens from clinical studies to determine correlations between biomarkers and outcomes in patients
  • Promoting collaborations between SPOREs, Cancer Centers, other NCI/NIH funded mechanisms and programs, and outside organizations
  • Promoting pilot projects and career enhancement of researchers new to translational research
  • Supporting research in high incidence and rare cancers
  • Encouraging communication with advocates and advocate organizations to obtain advice from the patient perspective

Contact TRP staff for more information on the SPORE program.